Speaker illustration

Doctor Peter Henriksen

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

Consultant Cardiologist, Edinburgh Heart Centre, Honorary Senior Lecturer, University of Edinburgh, Edinburgh UK. • Consultant Cardiologist with specialist expertise in percutaneous coronary intervention and cardio-oncology • Wellcome Trust PhD Fellowship, Centre for Inflammation and Repair, University of Edinburgh: Antiproteases and atherosclerosis • Clinician Scientist Fellowship 2012- ongoing support for dedicated research time • CI on > £1.5 million research grant funding form MRC/NIHR to support clinical trial work Research Interests; Detection and prevention of myocardial injury • Neutrophil elastase inhibitor Elafin- collaboration with Proteo Biotech- CI of first in man EMPIRE Study • Cancer chemotherapy (anthracycline) related heart muscle injury- CI of UK multi-centre Cardiac CARE study • Clinical trials (translation through to late phase)

Cardiovascular risk of cancer therapy

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session type: Abstract Sessions

Thumbnail